Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene?

 
• By Cathy Kelly

Insurance plans put on notice that CMS is concerned about restrictions on drugs with negotiated prices, but it’s not clear what the agency can or will do about it.

A Lack Of Rebates or Discounts For Negotiated Part D Drugs Could Impact Premiums. • Source: Shutterstock

More from Pricing Debate

More from Market Access